SCHEMBL28043969

SCHEMBL28043969

Cc1cc(C)cc(-c2cc(NCc3ccc4cn[nH]c4c3)nc(N)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 2/20 0.43
▸ PDPK1 O15530 2/20 0.43
▸ TGFBR1 P36897 2/20 0.43
▸ AURKB Q96GD4 2/20 0.43
▸ INSR P06213 1/20 0.43
▸ IGF1R P08069 1/20 0.43
▸ CLK1 P49759 3/20 0.41
▸ DYRK1A Q13627 3/20 0.41
▸ CLK4 Q9HAZ1 3/20 0.41
▸ CLK2 P49760 2/20 0.41
▸ DYRK1B Q9Y463 2/20 0.41
▸ AGPAT2 O15120 2/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KDR P35968 4/20 0.40
▸ APAF1 O14727 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043889 0.91 TGFBR1 (0.43) AURKAPDPK1TGFBR1AURKBCLK1
SCHEMBL15757372 0.81 NUDT1 (0.54) AURKAPDPK1TGFBR1AURKBINSR
SCHEMBL28151194 0.76 NPC1 (0.49) AURKAPDPK1TGFBR1AURKBKDM4E
SCHEMBL28152251 0.74 CA1 (0.55) —
SCHEMBL28043938 0.74 PTGS2 (0.54) —
SCHEMBL15757718 0.73 NUDT1 (0.54) TGFBR1AURKBCLK1DYRK1ACLK4
SCHEMBL28151149 0.73 HRH4 (0.64) AURKAPDPK1TGFBR1AURKBHRH4
SCHEMBL28151182 0.72 HRH4 (0.52) ALDH1A1HRH4SMN1; SMN2
SCHEMBL28267611 0.72 HRH4 (0.43) AURKAPDPK1TGFBR1AURKBKDM4E
SCHEMBL28043772 0.71 AURKA (0.54) AURKAPDPK1TGFBR1AURKBHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 — — CN disclosed
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 — — CN disclosed
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 — — CN disclosed
Send feedback